Works matching IS 1399543X AND DT 2022 AND VI 23 AND IP 2


Results: 10
    1
    2
    3

    A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes.

    Published in:
    Pediatric Diabetes, 2022, v. 23, n. 2, p. 173, doi. 10.1111/pedi.13279
    By:
    • Shankar, R. Ravi;
    • Zeitler, Philip;
    • Deeb, Asma;
    • Jalaludin, Muhammad Yazid;
    • Garcia, Raymundo;
    • Newfield, Ron S.;
    • Samoilova, Yulia;
    • Rosario, Carmen A.;
    • Shehadeh, Naim;
    • Saha, Chandan K.;
    • Yilong Zhang;
    • Zilli, Martina;
    • Scherer, Lynn W.;
    • Lam, Raymond L. H.;
    • Golm, Gregory T.;
    • Engel, Samuel S.;
    • Kaufman, Keith D.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin.

    Published in:
    Pediatric Diabetes, 2022, v. 23, n. 2, p. 183, doi. 10.1111/pedi.13282
    By:
    • Jalaludin, Muhammad Yazid;
    • Deeb, Asma;
    • Zeitler, Philip;
    • Garcia, Raymundo;
    • Newfield, Ron S.;
    • Samoilova, Yulia;
    • Rosario, Carmen A.;
    • Shehadeh, Naim;
    • Saha, Chandan K.;
    • Yilong Zhang;
    • Zilli, Martina;
    • Scherer, Lynn W.;
    • Lam, Raymond L. H.;
    • Golm, Gregory T.;
    • Engel, Samuel S.;
    • Kaufman, Keith D.;
    • Shankar, R. Ravi
    Publication type:
    Article